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tObjective: To compare a complex nondrug intervention including ac-
tively approaching counseling and caregiver support groups with dif-
fering intensity against usual care with respect to time to institution-
alization in patients with dementia. Methods: Within this three-
rmed cluster-randomized controlled trial, 390 community-dwelling
atients aged 65 years or older with physician-diagnosed mild to mod-
rate dementia and their caregivers were enrolled via 129 general prac-
itioners in Middle Franconia, Germany. The intervention included
eneral practitioners’ training in dementia care and their recommen-
ation of support groups and actively approaching caregiver counsel-
ng. Primary study end point was time to institutionalization over 2
ears. In addition, long-term intervention effects were assessed over
time horizon of 4 years. Secondary end points included cognitive
unctioning, (instrumental) activities of daily living, burden of care-
iving, and health-related quality of life after 2 years. Frailty models
ith strict intention-to-treat approach and mixed linear models
ere applied to account for cluster randomization. Health care costs
nomi
al So
http://dx.doi.org/10.1016/j.jval.2012.06.007ere assessed from the societal perspective. Results: After 2 (4)
ears, 12% (24%) of the patients were institutionalized and another
1% (35%) died before institutionalization. No significant differences
etween study groups were observed with respect to time to insti-
utionalization after 2 and 4 years (P 0.25 and 0.71, respectively).
econdary end points deteriorated, but differences were not signif-
cant between study groups. Almost 80% of the health care costs
ere due to informal care. Total annual costs amounted to more
han €47,000 per patient and did not differ between study arms.
Conclusion: The intervention showed no effects on time to institu-
tionalization and secondary outcomes.
Keywords: basic and instrumental activities of daily living, burden of
care, caregiver support groups, family counseling, health-related qual-
ity of life, informal care, time to institutionalization, MMSE.
Copyright © 2012, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Dementia is one of the most common diseases in older people
and a major cause of disability and mortality [1]. Currently,
about 7% or 1.2 million people of the German population aged 65
years and older suffer from dementia [2], and prevalence rates
in other European countries have been estimated to range be-
tween 6% and 9% [3]. Because of rising life expectancy, preva-
lence is expected to further increase over the next decades.
Dementia is associated with a high societal and economic bur-
den. In an ageing society in which soon a third of the population
will be older than 65 years, this burden will increase even more,
* Address correspondence to: Petra Menn, Institute of Health Eco
Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
E-mail: petra.menn@helmholtz-muenchen.de.
1098-3015/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.with serious consequences on health care systems and society
in general. High costs for the health care system are associated
with dementia care, especially after patients have been institu-
tionalized. From a societal perspective, costs before institution-
alization are substantial due to the high cost of informal care [4].
Most patients with dementia who live in their home environ-
ment receive informal care from family members, neighbors, or
friends [5]. Mostly, patients as well as informal caregivers wish
to extend the time the patient lives at home [6], which would
also relieve the cost burden on health care systems. It is there-
fore important to support informal caregivers to ensure care
for the increasing number of patients with dementia in the
future.
cs and Health Care Management, Helmholtz Zentrum München,
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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852 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9In dementia care, it is of salient importance to understand to
which extent sustainable support by informal care is able to ex-
tend the time the patient lives at home. In addition to medical
therapy, guidelines for patients with dementia living at home in-
clude nonpharmaceutical measures such as counseling and sup-
port groups, both to delay institutionalization and to relieve care-
giver burden. However, several international studies evaluating
the effect of such nonmedical interventions on institutionaliza-
tion have yielded inconclusive results: While Mittelman et al. [7]
observed a significant delay in nursing home placement following
a caregiver support intervention in a study with caregivers partic-
ipating at least twice in individual counseling, others found no
effect of case management or collaborative care for caregivers on
the rate of institutionalization [8–10].
Meta-analyses have also been conducted to analyze the effect
f support programs for caregivers of patients with dementia, and
ndings of Spijker et al. [11] suggest that these programs increase
ime to institutionalization, with a mean difference of 4.9 months.
imiting this analysis to the best-quality studies, however, again
ielded a nonsignificant difference in time to institutionalization.
nother meta-analysis concluded that multicomponent interven-
ions reduce the risk for institutionalization but did not assess
ime to institutionalization [12].
With respect to caregiver burden, no significant effect of case
anagement was observed in the MADDE study [13], while Pin-
uart and Sorensen [12] found a significant effect of multicompo-
nent interventions in their meta-analysis. Also, disease manage-
ment programs showed a positive effect on patients’ health-
related quality of life [14]. In sum, evidence remains inconclusive
on how caregiver support influences the patient’s time to institu-
tionalization.
The aim of this study was to compare a complex nondrug in-
tervention including counseling and caregiver support groups
against usual care in terms of time to nursing home placement. In
contrast to the studies mentioned above, participants were not
obliged to participate in the caregiver support groups or counsel-
ing in order to enhance the generalizability of results to normal
dementia care. The main research questions were threefold and
were addressed by the primary (1), secondary (2), and economic
analyses (3): 1) Is a complex nondrug intervention for patients with
dementia living at home, their caregivers, and doctors more effec-
tive than usual care with respect to postponement of nursing
home placement? 2) Does the intervention have an effect on dis-
ease progression and on caregiver burden? 3) If the intervention
should prove to be effective, is it also cost-effective from a societal
perspective?
Methods
Study
The German IDA (Initiative Demenzversorgung in der Allgemein-
medizin, Dementia Care Initiative in Primary Practice) project was
designed as a three-armed cluster-randomized trial in which pa-
tients with dementia and their informal caregivers were recruited
by general practitioners (GPs). Patients in the study region of Mid-
dle Franconia, Bavaria, Germany, were included if they had phy-
sician-diagnosed mild or moderate dementia, had a Mini-Mental
State Examination (MMSE) score ranging from 10 to 24, were at
least 65 years old, and were members of the AOK Bavaria - Health
insurer. Patients were excluded if they had terminal illness, if
nursing home placement was already planned, or if they were not
able or not willing to give informed consent. Severity of dementia
was determined with the MMSE, with a score of 18 to 24 indicating
mild dementia and a score of 10 to 17 indicating moderate demen-
tia. Signed informed consent of patients and informal caregivers
was required before study inclusion. Study recruitment took placefrom June 2005 to December 2006, and the duration of the inter-
vention phase was 2 years. To also assess possible long-term in-
tervention effects, data on institutionalization and death were col-
lected over a time horizon of 4 years. The study was approved by
the Ethics Committee at the Bavarian Chamber of Physicians (No.
05029, date of approval: May 30, 2005) and is in compliance with
the Helsinki Declaration.
Randomization
IDA is a cluster-randomized study where the general practices
are the clusters and thus the units of randomization. If two or
three GPs from the same group practice wanted to participate in
the study and attended the training course, they were random-
ized into the same study arm. GPs were randomly assigned to the
three study arms by permuted blocked randomization, which was
stratified by study region and type of practice (single vs. group). The
randomization was carried out by the statistics and data center by
using an allocation ratio of 1:1:1 as described in the study protocol
[15].
Intervention
Training of GPs
To ensure that patient inclusion did not differ systematically across
intervention groups, GPs in all study groups participated in a training
course on dementia diagnosis that covered basic information about
dementia, anamnesis and physical examination, laboratory diagnos-
tics, and psychometric tests (120 minutes). GPs were then informed
to which study arm they had been randomized.
In group A, drugs and nonmedical treatment options were not
part of the training, and so this level of knowledge served as a
proxy for the general status quo. This group served as a control
group in which patients received usual care. GPs in the two inter-
vention groups B and C additionally received training on evidence-
based dementia treatment (140 minutes), which was based on the
dementia guideline for GPs from the Witten-Herdecke University
(http://www.evidence.de) and the therapy recommendations of the
Pharmaceutical Commission of the German Medical Association. It
contained information about interfaces in the German health care
system, non–medication-based treatment, information and counsel-
ing of caregivers, medical treatment options, therapy of noncognitive
disorders, and specific problems. The therapeutic and diagnostic part
of the training was given by five neurologists or psychiatrists with
proven gerontopsychiatric expertise. A more detailed description
has been published elsewhere [15].
Recommendation of support groups and family counseling
In groups B and C, GPs suggested that caregivers should attend a
caregiver support group that offers professional supervision and a
psychoeducational element to improve caregivers’ competencies
and that holds at least 10 formal meetings per year [15].
In addition, GPs recommended caregiver counseling beginning
either at baseline (study arm C) or after the 1-year follow-up (study
arm B). Following the concept of Counselors Contact Caregivers,
the counselors contacted caregivers to establish a direct personal
contact, and they used case and care management to support
caregivers so that the patient could remain in the domestic envi-
ronment as long as possible. Four state-registered nurses or
nurses trained in the care of the elderly with several years of ex-
perience in psychogeriatric care offered counseling by actively ap-
proaching the family by using elements of case management. Top-
ics included the physical and the emotional situation of the
patient and the caregiver, the general framework, caregiving ac-
tivities, and social support. Actively approaching the caregivers
should enable earlier planning of assistance than if family mem-
bers need to establish contact.
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853V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9As the primary contact person, the GP provides information on
support services for patients with dementia and their caregivers [16].
It is therefore important that counseling is recommended by the GP.
A more detailed description of the concept of counseling and the
intervention given by the GPs has been published elsewhere [16].
Usage of these offers was, however, voluntary and not requisite
or study participation.
Assessments and measures
Primary outcome
Primary study end point was the remaining time the patient lived
at home, defined as time from study entry until nursing home
placement (for at least 8 weeks) over a time horizon of 2 years. To
also assess possible longer-term intervention effects, data on in-
stitutionalization and death were additionally collected until 2
years after the end of the 2-year intervention phase, resulting in a
total time horizon of 4 years. In a sensitivity analysis, time until
nursing home placement or death was evaluated as a combined
end point.
Secondary outcomes
Five secondary patient and caregiver outcome parameters were
examined at the end of the 2-year intervention period: 1) Subjec-
tive burden of informal caregivers as measured by the Burden
Scale for Family Caregivers (BSFC). The BSFC takes values from 0 to
72, with higher values indicating a higher subjective burden [17]
and values below 35 are associated with mild subjective burden. 2)
Cognitive functioning (MMSE). The MMSE takes values from 0 to 30
[18], with lower values indicating higher cognitive impairment.
Scores from 18 to 24 were categorized as mild dementia, and
scores from 10 to 17 were categorized as moderate dementia. 3)
Ability to perform activities of daily living (ADL) as measured by
the Barthel Index. Values range between 0 and 100 points, where
lower values denote a higher need for support [19]. (4) Ability to
perform instrumental ADL (IADL) as measured by the IADL sub-
scale of the Nurses’ Observation Scale for Geriatric Patients
(NOSGER). On a scale from 5 to 25, higher values indicate higher
impairment [20] and a score above 10 is classified as pathologic. 5)
atient’s health-related quality of life based on EuroQol five-di-
ensional (EQ-5D) questionnaire utilities. The descriptive part of
he EQ-5D questionnaire was completed by the informal caregiver
rom the patient’s perspective, while the visual analogue scale
as not applied because of its low reliability in dementia [21]. To
alculate utilities, the German tariff based on time trade-off was
sed, yielding utility values ranging from 0.3 to 1 [22].
The MMSE was conducted by the GPs, whereas the remaining
econdary outcome parameters were collected in telephone inter-
iews with the caregivers. Both GPs and caregivers were contacted at
aseline, after 1 year, and again after 2 years but were not contacted
fter a patient had died or had been admitted to a nursing home. A
etailed description has been given in the study protocol [15].
Economic outcomes
To be able to perform a cost-effectiveness analysis with respect to
the primary end point as effectiveness parameter, health care
costs were assessed from the societal perspective. Data were col-
lected from caregivers as well as from the statutory health insur-
ance and long-term care insurance from study entry until the end
of the 2-year intervention period or until nursing home placement
or death. Patients who withdrew their consent were excluded
from all cost analyses. Costs were inflated to 2008 prices by using
the gross domestic product deflator. For costs occurring in the
second study year, a discount rate of 3% was applied [23].
Costs for inpatient and outpatient care, prescribed drugs,
rehabilitation, medical aids, and nonphysician services werecalculated from statutory health insurance data. Transfer pay-
ments were excluded from analyses from the societal perspec-
tive. Although out-of-pocket payments were assessed within
interviews, they were not included because caregivers often
were not able to specify the amount of costs. Because most
chronically ill patients in this age group are excluded from co-
payments, omission of out-of-pocket costs is only a minor con-
cern in our patient sample and is unlikely to affect cost differ-
ences between groups.
Informal care time of all involved caregivers was assessed
within telephone interviews with the primary caregiver at three
time points. An extended version of the specific questions on in-
formal care time of the Resource Utilization in Dementia instru-
ment [24] was applied. Informal care was assessed by days during
the last 4 weeks, and caregivers were asked how many hours a day
they and other informal caregivers assisted the patient in ADL and
IADL [25,26]. Supervision time was not included in the base anal-
ysis. Applying the substitution cost approach, ADL hours were
valued by using wage rates of professional ambulatory nurses at
€28.30 [27], while for IADL time, costs of a professional housekeeper
of €16.54 were used. For caregivers who did not share a household
with the patient, travel costs were set at €3.40 per day [27].
Estimated intervention costs consisted of labor and overhead
osts for counselors and caregiver support groups. Study-specific
osts, which would not occur in routine application, were not con-
idered. Based on participation rates at support groups and reim-
ursement costs by the health insurance, costs of €20 and €12.50
er session were assumed for visits with and without patient su-
ervision, respectively. Costs for counselors were based on num-
er and duration of patients entitled to counseling.
In a first sensitivity analysis, costs were calculated from the
erspective of the health insurance, where no discounting was
pplied and prices were not inflated to a base year; instead, actual
xpenditures were reported. In a second sensitivity analysis, costs
ere again assessed from the societal perspective, but now we
dditionally considered time spent for supervising the patient,
hich was valued by using wage rates of a professional house-
eeper of €16.54 in accordance with time for IADL.
A more detailed description of the assessment of economic
utcomes can be found elsewhere [28].
In addition, baseline information on age and sex of the patient
nd the caregiver, time since first dementia diagnosis, and pres-
nce of additional caregivers was collected. Also, a disorder score
nd a score on the use of support services were assessed. The
isorder score was defined as the number of the following 10
ymptoms present: apraxia, aphasia, wandering, aggressiveness,
gitation, incontinence, hearing impairment, visual impairment,
epression, and delusion. The score on the use of support services
as defined as the number of the following 7 services used at
aseline: caregiver support groups, caregiver counseling, outpa-
ient nursing, meals on wheels, household help, visiting voluntary
elpers, and day care groups.
To assess patients’ comorbidity, the Incalzi index was used
29], which was specifically developed for geriatric patients and
herefore seemed best suited for this patient group. Physician-
eported diagnoses and International Statistical Classification of Dis-
ases, 10th Revision, diagnoses from health insurance data were
sed to assess the presence of each comorbid condition.
Statistical analysis
Primary outcome
To evaluate the primary hypothesis, a time-to-event analysis with
strict intention-to-treat approach was conducted. We assessed
differences between study groups both after 2 years and addition-
ally after 4 years. Patients who still lived at home 2 (4) years after
study entry were censored after 2 (4) years, patients who died
854 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9without nursing home placement were censored at the time of
death, and patients who withdrew their consent were censored at
the time of withdrawal. First, unadjusted Kaplan-Meier survival
curves were reported. Log-rank tests were applied to examine the
statistical significance of the difference between study groups. In a
second step, a frailty model was applied. Frailty models extend
standard survival models by random effects to account for cluster
randomization [30]. Selection of potential confounders was based
on a systematic review [31], and analyses were adjusted for age
and sex of the patient and the caregiver, time since first dementia
diagnosis, MMSE score, Barthel Index, BSFC values, presence of
additional caregivers, the disorder score, and the score on the use
of support services. In the sensitivity analysis on the combined
end point of institutionalization and death, the Incalzi comorbid-
ity index was included as an additional confounder. In all models,
pairwise comparisons between groups were conducted only if an
overall effect of study group was significant with a significance
level of 5% to account for multiple testing. Missing values in po-
tential confounders were imputed on the basis of an expectation-
maximization algorithm [32] by using available information from
baseline GP assessment, telephone interview, and health insur-
ance data to include all patients in the analysis.
Because GP-specific data were not available for all GPs, analy-
ses were not adjusted for GP characteristics. For those GPs whose
information was available, however, there were no differences be-
tween study groups with regard to age, years in practice, and pro-
portion of GPs who work in a group practice [33]. Also, the GP-
specific random effects that were included in all analyses should
adjust the results for possible effects of GP characteristics.
Secondary outcomes
To assess the effect of the intervention on secondary outcome
parameters after 2 years, mixed linear models were used with
postintervention values as outcome and baseline values as ex-
planatory variable for patients still alive after 2 years. Structural
differences between groups were accounted for by additionally
adjusting for age and sex of patients and caregivers. Random ef-
fects for GP were included to account for cluster randomization.
Missing values occurred as part of the study design, because
GPs and caregivers were not contacted after the patient had
moved to a nursing home. In addition, missing values occurred if
GPs or caregivers could not be contacted, were unwilling to partic-
ipate, or had single missing items. As base case, a complete case
analysis was conducted. However, this assumes that missing val-
ues occur completely at random. Because this assumption is un-
likely to hold because of study design, because more impaired
patients are more likely to move to a nursing home and thus to
have missing values at the 2-year follow-up, two sensitivity anal-
yses were performed: First, missing values were imputed for all
patients still alive after 2 years by using multiple imputation
methods [32], where each missing value was replaced by 10 sim-
ulated values by using the regression method in SAS V9 including
age, sex, and care level of the patient as independent variables.
Missing BSFC values were imputed for patients living at home
only, because in this case no reasonable values can be imputed.
Multiple imputation assumes, however, that missing values occur
at random, that is, they depend on observed values only, whereas
in this study, missing values are likely to be not at random, be-
cause the health state of patients who moved to a nursing home
probably deteriorated more than that of other patients. Therefore,
in a second sensitivity analysis, pattern mixture models were ap-
plied, where no such assumption is made and missing values may
occur not at random [32]. Missing values in the confounding vari-
ables age and sex of patient and caregiver were imputed as de-
scribed for the primary hypothesis.Economic outcomes
A linear interpolation of informal care hours per day was assumed
between interviews. For those patients who moved to a nursing
home or died within 2 years, costs for informal care were esti-
mated until the event occurred by calculating average increase in
informal care for complete cases and applying this increase to
incomplete patients until time of dropout. For caregivers who did
not participate in any interview, hours of informal care time at
baseline were estimated on the basis of baseline patient data and
health insurance data. For follow-up interviews as well as for sin-
gle missing interviews, hours were estimated by applying mean
changes observed in complete cases as described for dropouts.
To calculate mean costs per year lived at home, observed costs
were adjusted for time at risk by weighting total costs with time
living at home. Differences in costs between study groups were
tested for significance by using Kruskal-Wallis tests to account for
the highly skewed distribution of cost variables. However, this
approach does not account for the cluster randomization. We in-
tended a formal cost-effectiveness analysis with incremental
costs per additional year living at home as outcome parameter and
planned sensitivity analyses by using the bootstrap approach to
calculate confidence intervals for incremental cost-effectiveness
ratios.
The significance level for all analyses was 5%. The program R,
version 2.7.2, was used to calculate frailty models, and the soft-
ware package SAS, version 9.1 (SAS Institute, Inc., Cary, NC), was
used for all other analyses.
Results
In all, 303 GPs were randomized, constituting about 25% of all the
GPs eligible; 220 of them participated in the training for diagnosing
dementia and 129 of these (59%) recruited a total of 390 patients
(Fig. 1). The number of patients per GP varied from 1 to 24. Infor-
mation on the primary end point was available for 383 patients,
and at least one interview was obtained from 369 caregivers.
Patient and caregiver characteristics at baseline for each of the
three study groups are shown in Table 1. On average, patients
were 80 years old, 68% were women, and two third had mild de-
mentia. Most frequent comorbidities were hypertension, diabetes,
and heart failure. Caregivers had a mean age of 59 years, and 73%
of them were women. Mean values of the Barthel Index, the EQ-5D
questionnaire, and the MMSE were somewhat worse in group C
than in groups A and B, but these differences were not statistically
significant. Apart from the age of caregiver—with younger care-
givers in B—baseline characteristics did not differ significantly
between study groups.
Primary outcome
Within 2 years after study entry, a total of 47 patients (12%) had
moved to a nursing home, 80 patients (21%) were censored be-
cause of death, and another 7 (2%) withdrew their consent before
an event occurred, while 256 patients (66%) were still living at
home at the end of follow-up. After 4 years, 24% of the patients
were institutionalized, 35% had died, 2% had withdrawn their con-
sent, and 39% were still living at home.
Unadjusted Kaplan-Meier-curves for time to nursing home
placement are shown in Figure 2, and no differences were ob-
served for the three study groups (associated P value based on a
log-rank test of 0.31 after 2 years and 0.74 after 4 years). The intra-
cluster correlation coefficient for the primary end point after 2
years was 0.03.
Results of the frailty model over the 4-year time horizon are
summarized in Table 2. The overall P value for study group was not
significant (0.71), while age of the patient, Barthel Index, BSFC val-
ues, the presence of additional caregivers, and score on the use of
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855V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9support were significant predictors of time to nursing home place-
ment, where higher values and the presence of additional caregiv-
ers were associated with an increased institutionalization rate.
With respect to study group, results agree with the unadjusted
analysis and also with the frailty model over the 2-year time hori-
zon (not shown).
In the sensitivity analysis where time to nursing home place-
ment and death was analyzed as a combined end point, differ-
ences between study groups remained nonsignificant (P  0.25),
and patient age, Barthel Index, and score on the use of support
were again significant predictors (not shown). A per-protocol anal-
ysis was performed as an additional sensitivity analysis, which
included only those patients who lived at home for 6 months and
therefore had a chance to benefit from the intervention. The re-
sults for the primary end point, however, remained unaltered.
Secondary outcomes
Table 3 summarizes the results of the secondary analyses for pa-
ients still living at home 2 years after study entry (n 256). In the
-year follow-up, mean values of BSFC increased by 5 points, indi-
ating a rising subjective burden of caregiving. The proportion of
aregivers reporting only mild subjective burden decreased from
3% to 66%. In the same time, patient outcomes declined consid-
rably, with the mean Barthel Index decreasing by 6 points and the
ean MMSE score by 1.5. NOSGER IADL worsened by 2 points, and
Q-5D questionnaire values worsened by 0.12. The proportion of
Fig. 1 – CONSORT flow chatients with NOSGER IADL values of 10 and above increased from79% to 89%. After adjusting for baseline values and age and sex
of patient and caregiver, however, none of the secondary end
points differed significantly between study groups after 2 years.
Intracluster correlation coefficient was 0.004 (BSFC), 0.14
(MMSE), 0.12 (Barthel Index), 0.05 (NOSGER IADL), and 0.03
(EQ-5D questionnaire).
Results from sensitivity analyses using multiple imputation
methods and pattern mixture models differed only marginally
with respect to adjusted mean values at 2-year follow-up, with
slightly higher P values compared with base analysis (not shown).
Economic outcomes
Costs until nursing home placement over the 2-year study period
were analyzed for all 383 patients who did not withdraw their con-
sent. For each cost component, costs from the societal perspective
are shown in Table 4 for the three study groups. By far the highest
contribution was from informal care, accounting for about 78% of the
total costs. During follow-up, 68% of the patients were hospitalized at
least once, resulting in an average of 21 days of inpatient care. Patients
had a mean of 62 drug prescriptions, and 10% of the patients received
rehabilitation. Total costs did not differ significantly between study
groups (P 0.64). Differences in costs between groups were significant
for outpatient care only (P 0.03), with lower costs in group A.
When adjusted for time at risk, mean annual health care costs
amounted to €47,885 per patient, with no significant differences
between groups (group A: €48,598, group B: €46,178, and group C:
GP, general practitioner.art.€48,587). Results of a formal cost-effectiveness analysis are not
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856 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9shown because the effectiveness of the intervention with regard to
the primary end point could not be shown.
The first sensitivity analysis evaluating costs from the health
insurance perspective resulted in mean costs of €18,520 over the
2-year period, and again no significant differences between study
groups were observed (group A: €17,905, group B: €18,311, and
group C: 19,680; P  0.29). For the most part, the difference com-
pared with base costs is due to informal care, which is not consid-
ered from the perspective of the health insurance. Costs per year
at risk amount to €11,072 (group A: €10,516, group B: €10,522, and
roup C: €12,623).
Table 1 – Patient and caregiver characteristics at baseline.
Patient
Age (y)
Sex (% females)
Previous diagnosis of dementia (%)
Years since first diagnosis for those previously diagnosed
MMSE
% mild (18–24)
% moderate (10–17)
Barthel Index
NOSGER IADL
EQ-5D questionnaire
Hypertension (%)
Diabetes (%)
Heart failure (%)
Incalzi comorbidity index
Informal caregiver
Age (y)
Sex (% females)
Social relationship with patient (%)
Partner
Daughter/son (-in-law)
Other
BSFC value
Note. Data are mean  SD unless noted otherwise.
BSFC, Burden Scale for Family Caregivers; EQ-5D, EuroQol five-dimens
activity of daily living subscale of the Nurses’ Observation Scale for GFig. 2 – Kaplan-Meier curve.In the second sensitivity analysis, where in addition to the
ase analysis the time the caregiver spends on supervising the
atient was included in the assessment, total costs per patient
ncreased to €102,583 over the study period of 2 years (group A:
106,295, group B: €99,626, and group C: €99,800; P  0.74). This
ise resulted from an average supervision time of 1.9 hours per
ay per patient at baseline, which increased to 2.3 hours per day
y the end of the 2-year follow-up. Here, adjusting for time at
isk resulted in mean costs per year of € 61,325 (group A: €62,430,
roup B: €57,248, and group C: €64,010).
oup A
 171)
Group B
(n  109)
Group C
(n  110)
P
8  7.2 79.1  6.4 80.9  6.3 0.17
66.7 67.9 70.9 0.81
71.9 62.4 70.9 0.47
2  2.6 2.2  2.4 2.4  2.8 0.62
8  3.8 18.9  3.6 18.4  3.9 0.87
66.7 67.9 60.0 0.60
33.3 32.1 40.0
5  26.1 77.5  24.8 68.8  28.2 0.13
8  5.3 15.7  5.1 16.1  5.7 0.87
3  0.29 0.59  0.31 0.51  0.32 0.18
54.5 60.6 54.6 0.72
38.6 35.8 45.5 0.32
25.2 25.7 22.7 0.84
6  2.1 3.7  2.4 3.5  2.1 0.76
9  12.9 55.5  13.5 60.8  13.4 0.003
72.7 73.3 74.3 0.96
36 25 34
57 68 53 0.13
7 7 13
6  17.2 25.2  16.7 26.3  17.7 0.80
; MMSE, Mini-Mental State Examination; NOSGER IADL, instrumental
ric Patients.
Table 2 – Results of the frailty model on time to
institutionalization over the 4-y time horizon.
Variable Hazard
rate
95% confidence
interval
P
Group B 0.858 0.473–1.556 0.614
Group C 1.133 0.639–2.011 0.668
Patient age 1.059 1.021–1.098 0.002
Female patient 1.199 0.652–2.206 0.559
Duration of diagnosis of
dementia
1.044 0.954–1.143 0.352
Caregiver age 1.018 0.998–1.038 0.075
Female caregiver 1.216 0.710–2.082 0.476
MMSE 0.969 0.911–1.031 0.319
Barthel Index 1.012 1.001–1.024 0.034
Disorder score 0.924 0.785–1.087 0.339
BSFC value 1.022 1.008–1.036 0.002
Additional caregiver present 1.805 1.098–2.966 0.020
Score on the use of support 1.886 1.469–2.420 0.001
BSFC, Burden Scale for Family Caregivers; MMSE, Mini-Mental StateGr
(n
80.
2.
18.
72.
15.
0.5
3.
60.
24.
ionalExamination.
857V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9Details on the formal cost-effectiveness analysis are not shown
because neither cost nor effects differed significantly between
groups, and therefore bootstrap replications were scattered across all
four quadrants of the cost-effectiveness plane both from the societal
perspective and from the perspective of the statutory health insur-
ance.
Discussion
This three-armed, cluster-randomized study on dementia manage-
ment explored the effect of a nondrug intervention mediated by GPs
including caregiver support groups and counseling on time to nurs-
ing home placement over 4 years. No significant differences between
study groups were observed with respect to time to institutionaliza-
tion, to secondary end points, and to health care costs.
Strengths of the study were the long follow-up of 4 years for
time to institutionalization and 2 years for the secondary and eco-
nomic end points, as well as the availability of complete health
insurance data for all patients. Also, with a sample size of 390
patients and their caregivers, IDA is internationally one of the
largest intervention studies on ambulatory care in dementia. An-
other distinctive characteristic of this study was that patients
were approached by GPs, who play a key role in access to unse-
lected patients with dementia and their caregivers. This patient
group differs from preselected patients who can be contacted
through specialists or memory and university clinics.
One problem of the study was structural differences at baseline
between study groups, with patients in group C being somewhat
more impaired than patients in groups A and B. This was particu-
Table 3 – Mean baseline and adjusted 2-y follow-up
values of secondary end points.
Secondary end point Group
A
Group
B
Group
C
P
BSFC
n 83 60 53
Baseline 23.6 24.5 22.1
Adjusted 2-y follow-up* 29.0 29.1 27.8 0.78
MMSE
n 98 63 40
Baseline 19.1 18.8 19.0
Adjusted 2-y follow-up* 18.3 16.6 17.2 0.26
Barthel Index
n 86 64 54
Baseline 75.5 81.8 77.3
Adjusted 2-y follow-up* 64.2 63.3 65.6 0.83
NOSGER IADL
n 86 64 54
Baseline 15.6 14.6 14.6
Adjusted 2-y follow-up* 16.8 17.7 17.3 0.25
EQ-5D questionnaire
n 85 64 54
Baseline 0.58 0.65 0.58
Adjusted 2-y follow-up* 0.49 0.43 0.51 0.23
Note. Numbers are based on the complete case analysis; results
after multiple imputation and from the pattern-mixture model dif-
fer only slightly.
BSFC, Burden Scale for Family Caregivers; EQ-5D, EuroQol five-di-
mensional; MMSE, Mini-Mental State Examination; NOSGER IADL,
instrumental activity of daily living subscale of the Nurses’ Obser-
vation Scale for Geriatric Patients.
* Follow-up values are adjusted for baseline value and age and sex
of patient and caregiver.larly concerning in terms of the Barthel Index, with a difference of9 points between groups B and C on average. Marginal differences
occurred in MMSE, NOSGER IADL, and EQ-5D questionnaire val-
ues, also favoring groups A and B. Although none of these differ-
ences were statistically significant, they might indicate a generally
worse condition of this group, which also showed in a (nonsignifi-
cantly) increased mortality. This imbalance can be due to random
differences or due to a selection bias caused by the cluster ran-
domization, where all patients from one GP were in the same in-
tervention group. As GPs knew into which group they had been
randomized, this might have influenced patient recruiting and
participation consent. Although these observed baseline differ-
ences were accounted for in the analyses as far as possible, unob-
served imbalances may still have affected study outcomes.
Also, the inclusion criterion that only patients from one statu-
tory health insurance were eligible may limit generalizability, and
patients with a lower social status may be overrepresented. This
is, however, the largest health insurer in Germany and covers
about 40% of the population in the study region.
We observed a fairly low rate of institutionalization across all
study groups within the 4-year time horizon. In the AD2000 Col-
laborative Group, 25% of the patients were institutionalized within
2 years [34], whereas in IDA, a comparable proportion of institu-
tionalized patients was observed only 4 years after study entry.
This may be due to a higher proportion of patients with mild dis-
ease at baseline in our study, but the rate of institutionalization
could also depend on country-specific contexts. Also, 35% of the
patients died before a nursing home placement had occurred,
whereas in the AD2000 study, this percentage was only 10%, and
so the proportion of censored patients was higher than expected.
This difference may be attributed to a higher age in the IDA study,
where the median age at study entry was 5 years higher than that
in the AD2000 study, resulting in increased mortality.
In the study protocol, time to nursing home placement or death
was defined as a combined end point for the base analysis, and a
sensitivity analysis was planned to be conducted on nursing home
placement as a single outcome with death as a censoring event.
Because of the unexpectedly high proportion of death compared
with nursing home placements within the study period, however,
the order of these analyses was reversed and death was censored
in the base analysis, because in a combined end point, death may
have outweighed possible effects on nursing home placement. Yet
both analyses were conducted and yielded consistent results, par-
ticularly with regard to nonsignificant intervention effects.
The high proportion of patients with mild dementia and pa-
tients with a first diagnosis probably also affects secondary out-
come parameters such as caregiver burden or IADL functioning,
because the need of assistance is lower in mild disease.
Table 4 – Cost components from the societal perspective
(€) over the 2-y study period.
Cost component Group A Group B Group C
Total costs 82,745 80,361 75,754
Informal care 65,921 63,206 57,718
Inpatient care 7,251 5,976 5,664
Prescribed drugs 2,675 2,737 2,531
Long-term care insurance 2,375 2,068 2,694
Outpatient care 1,685 2,094 2,009
Home health care 1,321 1,159 845
Medical aids 614 675 548
Nonphysician services 419 660 287
Rehabilitation 483 248 252
Care managers — 1,533 3,204
Caregiver support groups — 3 4
858 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 5 1 – 8 5 9Lack of significance in both effects and costs prevented a
meaningful interpretation of the results of the cost-effectiveness
analysis. Cost analyses showed that the financial burden of pa-
tients with dementia living at home from the societal perspective
is substantial. Informal care time accounted for almost 80% of the
total costs, or even more when supervision time was also consid-
ered. Our results of mean costs per patient per year of €47,885
agree well with those of an earlier German study, where average
total costs of approximately €48,000 (inflated to 2008) were re-
ported, also with informal care as the largest share [35]. This other
study, however, differed methodologically from IDA, for example,
by including costs of institutionalization. Our results again con-
firm that without informal caregivers the costs for caring of pa-
tients with dementia would be multiplied several times.
A major difference between the intervention in the IDA project
and other studies on caregiver support in dementia was the vol-
untary participation in caregiver counseling and support groups. It
was the caregivers’ decision to use these services, and participa-
tion was not an inclusion criterion for the intervention group. This
optional character of the intervention better reflects the reality of
care and thus provides a high external validity of study results.
Furthermore, the pragmatic study design reflects a significant ad-
vance in health services research because it more accurately re-
flects real-world conditions [36]. In contrast, other studies require
a minimum number of contacts as inclusion criterion [7], and so
results of these studies probably are not directly transferable to
real-world conditions. On the other hand, the voluntary use in our
study may have resulted in a lower participation rate. Yet two
third of all caregivers in groups B and C had one or more direct
personal contact with a counselor [37]. In comparison to the control
group (A), the recommendation of actively approaching caregiver
counseling increased the use of counseling by 3.5 times—from 16% to
66%. This intervention effect, however, is not sufficient to achieve
significant differences in primary and secondary outcome parame-
ters between intervention groups and the control group. Because
caregivers, however, are contacted by the counselors instead of hav-
ing to seek assistance actively, it is possible to develop an early-onset
support plan. One could argue that the lower uptake of the interven-
tion in comparison to clinical studies with a minimum number of
contacts as inclusion criterion may have diluted a possible interven-
tion effect. According to the per-protocol analysis, however, this was
not the case. Also, though only 15% of the caregivers in groups B and
C had visited a support group within 2 years [37], this is considerably
higher than the previously reported 3% [6], a proportion that was also
observed in the control group A.
In all, the situation observed within the IDA study does not reflect
an artificial setting but rather shows realistic conditions that can be
expected when implementing this intervention. In view of the long-
term effects of the management strategies, some key challenges for
the development of future strategies in dementia management can
be derived from these real-world results: Optimizing the onset of
intervention to support caregivers, creating incentives to sustainable
participation in support programs, and consideration that support-
ing caregivers alone may have a limited potential in managing pro-
gressing disease within the patient’s home environment.
Source of financial support: The IDA project was initiated and
financed by four partners with equal rights in the conception, de-
velopment, and implementation: the Federal Association of the
AOK and the AOK Bavaria - Health insurer—one of the largest
statutory health insurances in Germany—and the research-based
pharmaceutical companies Eisai and Pfizer. The aim of this public-
private partnership is to improve the care of patients with demen-
tia and the support of their informal caregivers. The sponsors have
commissioned two academic research institutions with the scien-
tific evaluation of the IDA project by giving unconditional research
funds. A contract between the sponsors and academic researchers
ensures that the latter have the full scientific responsibility andhave the right to publish the results. Members of the sponsoring
organizations closely cooperate in design and conduct of the proj-
ect, but only the academic researchers have full access to all the
data in this study and take complete responsibility for the integrity
of the data and the accuracy of the data analysis.
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